Yoshimasa Tanaka

Overview

Best Publications

• Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade

  Yoshiko Iwai;Masayoshi Ishida;Yoshimasa Tanaka;Taku Okazaki

  3752
  Citations

• Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice

  Hiroyuki Nishimura;Taku Okazaki;Yoshimasa Tanaka;Kazuki Nakatani

  2255
  Citations

• Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer.

  Junzo Hamanishi;Masaki Mandai;Masashi Iwasaki;Taku Okazaki

  1812
  Citations

• Risk Factors Contributing to Type 2 Diabetes and Recent Advances in the Treatment and Prevention

  Yanling Wu;Yanping Ding;Yoshimasa Tanaka;Wen-Wen Zhang

  1377
  Citations

• Natural and synthetic non-peptide antigens recognized by human γδ T cells

  Tanaka Y;Morita Ct;Nieves E;Brenner Mb

  1329
  Citations

• Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice

  Taku Okazaki;Yoshimasa Tanaka;Yoshimasa Tanaka;Ryosuke Nishio;Tamotsu Mitsuiye

  796
  Citations

• Direct presentation of nonpeptide prenyl pyrophosphate antigens to human γδ T cells

  Craig T. Morita;Evan M. Beckman;Jack F. Bukowski;Yoshimasa Tanaka

  646
  Citations

• The Space Physics Environment Data Analysis System (SPEDAS)

  V. Angelopoulos;P. Cruce;A. Drozdov;E. W. Grimes

  543
  Citations

• The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors.

  David Yin-wei Lin;Yoshimasa Tanaka;Masashi Iwasaki;Apostolos G. Gittis

  531
  Citations

• Nonpeptide ligands for human gamma delta T cells

  Y Tanaka;S Sano;E Nieves;G De Libero

  500
  Citations

• The Human OX40/gp34 System Directly Mediates Adhesion of Activated T Cells to Vascular Endothelial Cells

  A Imura;T Hori;K Imada;T Ishikawa

  473
  Citations

• Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues.

  Masayoshi Ishida;Yoshiko Iwai;Yoshimasa Tanaka;Taku Okazaki

  390
  Citations

• V gamma 2V delta 2 TCR-dependent recognition of non-peptide antigens and Daudi cells analyzed by TCR gene transfer.

  J F Bukowski;C T Morita;Y Tanaka;B R Bloom

  364
  Citations

• Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study.

  Hirohito Kobayashi;Yoshimasa Tanaka;Junji Yagi;Yukinari Osaka

  304
  Citations

• Analyses of peripheral blood mononuclear cells in operational tolerance after pediatric living donor liver transplantation.

  Ying Li;Takaaki Koshiba;Atsushi Yoshizawa;Yukihide Yonekawa

  300
  Citations

• The C-kit receptor-mediated signal transduction and tumor-related diseases.

  Jing Liang;Yan-Ling Wu;Bing-Jia Chen;Wen Zhang

  297
  Citations

• TMPRSS2: A potential target for treatment of influenza virus and coronavirus infections

  Li Wen Shen;Hui Juan Mao;Yan Ling Wu;Yoshimasa Tanaka

  284
  Citations

• Small Molecules Targeting c-Myc Oncogene: Promising Anti-Cancer Therapeutics

  Bing-Jia Chen;Yan-Ling Wu;Yoshimasa Tanaka;Wen-Wen Zhang

  281
  Citations

• Essential Requirement of Antigen Presentation by Monocyte Lineage Cells for the Activation of Primary Human γδ T Cells by Aminobisphosphonate Antigen

  Fumi Miyagawa;Yoshimasa Tanaka;Seiji Yamashita;Nagahiro Minato

  233
  Citations

• Phase I/II study of adoptive transfer of γδ T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma

  Hirohito Kobayashi;Yoshimasa Tanaka;Junji Yagi;Nagahiro Minato

  221
  Citations